RB1 and cancer: In Bild et al. (2006) similar strategy was exploited in order to define the activity of several cancer-related pathways [MYC, RASA1 (RAS), SRC, Wnt/β-catenin and loss of RB function] on a large collection of human cancer transcriptomes.